Vanderbilt Health News Archive — Page 305 of 390

Two children stand beside stacks of cardboard boxes, holding a small handwritten note in front of a loaded cart.
March 21, 2013

Photo: Birthday wish

Hailey Willis, left, and her sister, Alyssa, stand in front of 22 boxes of gifts they donated to the Monroe Carell Jr. Children’s Hospital at Vanderbilt in honor of Hailey’s seventh birthday.

By Vanderbilt Health News
A woman and a man in a suit sit at a table talking; the man holds a pen above paperwork.
March 21, 2013

Spine surgeons tailoring treatment to each patient

When 55-year-old Neader Williams first learned that she might need spine surgery to treat her excruciating back and leg pain, she was more than a little scared and wasn’t even sure surgery was the answer.

By Vanderbilt Health News
March 21, 2013

Three take new roles in TRIAD

Staff of the Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) are assuming new roles.

By Vanderbilt Health News
Man in a suit and glasses speaking at a lectern in a lecture hall, with a microphone, computer monitor, and water bottle visible.
March 21, 2013

Photo: Discovery Lecture Seidman

Harvard’s Jonathan Seidman, Ph.D., discussed next-generation sequencing’s impact on cardiovascular genetics during his recent Flexner Discovery Lecture.

By Vanderbilt Health News
Three people on a stage celebrate during a Match Day event, with two jumping and raising papers while a man in a suit looks on; a projection screen is visible behind them.
March 21, 2013

Residency questions answered at Match Day

Match Day at Vanderbilt University School of Medicine (VUSM) has grown so popular the event moved from its traditional lecture hall setting at Light Hall to the more-spacious Langford Auditorium.

By Vanderbilt Health News
Two researchers in white lab coats pose in a laboratory beside workbenches and shelves of bottles and equipment.
March 21, 2013

Breast cancer study explores therapy to slow recurrence

Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.

By Vanderbilt Health News